Immune cell-mediated destruction of salivary glands is a hallmark feature of Sj€ ogren syndrome. Similar to the female predominance in humans, female non-obese diabetic (NOD) mice develop spontaneous salivary gland autoimmunity. However, in both humans and mice it is unclear what factors contribute to the initial immune infiltration of the salivary glands. Here, we used an adoptive transfer model of Sj€ ogren syndrome to determine if female mice harbor a sex-specific defect in salivary-gland-protective regulatory T (Treg) cells. Transfer of cervical lymph node (LN) cells from female NOD mice into sex-matched NOD-severe combined immunodeficient (SCID) recipients resulted in sialadenitis, regardless of the presence or absence of Treg cells. In contrast, transfer of cervical LN cells from male NOD mice into sex-matched NOD-SCID recipients only resulted in sialadenitis when Treg cells were depleted before transfer, suggesting that male NOD mice have functional salivary-gland-protective Treg cells. Notably, the host environment affected the ability of Treg cells to prevent sialadenitis with testosterone promoting salivary gland protection. Treg cells from male mice did not protect against sialadenitis in female recipients. Testosterone treatment of female recipients of bulk cervical LN cells decreased sialadenitis, and Treg cells from female mice were capable of protecting against development of sialadenitis in male recipients. Hence, our data demonstrate that female NOD mice develop sialadenitis through a defect in salivary-gland-protective Treg cells that can be reversed in the presence of testosterone.
Introduction
Sj€ ogren syndrome is an autoimmune disease that predominantly affects women and is characterized by dysfunction of the salivary and lacrimal glands as a result of immune cell-mediated destruction. 1 Factors contributing to the initiation of the autoimmune attack are poorly defined owing to the prolonged time (years) between initiation of autoimmunity and eventual diagnosis. 2 Hence, alternative models are required to fully understand the mechanisms that lead to the initial autoimmune attack. The non-obese diabetic (NOD) mouse is a well-established model of Sj€ ogren syndrome with spontaneous development of salivary and lacrimal gland autoimmunity. 3, 4 Similar to Sj€ ogren syndrome in humans, salivary gland autoimmunity in NOD mice occurs spontaneously with a female predominance. [5] [6] [7] In contrast, male NOD mice are protected from the development of salivary gland inflammation, 6, 7 but the factors responsible for these sex-specific differences in sialadenitis are not known.
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CD4
+ Foxp3 + regulatory T (Treg) cells suppress immune cell activation and are required for maintaining tolerance to self-antigens. 8 The importance of Treg cells is shown by the widespread autoimmunity found in mice and humans that lack this population because of mutations in the gene encoding the transcription factor Foxp3. 8 In non-autoimmune-prone mouse strains, genetic manipulations resulting in decreased Treg cells led to the development of sialadenitis, 9, 10 suggesting that Treg cells play a dominant role in preventing salivary gland autoimmunity in healthy individuals. However, whether Treg cells play a role in preventing salivary gland autoimmunity in male NOD mice has not been evaluated. Here we use an adoptive transfer model of Sj€ ogren syndrome to dissect the role of Treg cell dysfunction and sex hormones in the female-specific development of autoimmune sialadenitis.
Materials and methods
Mice
Male and female NOD/ShiLtJ (NOD), castrated and sham-castrated male NOD, and NOD.CB17-Prkdc scid /J (non-obese diabetic-severe combined immunodeficient; NOD-SCID) mice were purchased from The Jackson Laboratory (Bar Harbor, ME). NOD mice expressing the bicistronic Foxp3-green fluorescent protein (Foxp3 GFP ) reporter construct knocked into the endogenous Foxp3 locus 11 (NOD), were a kind gift from Vijay Kuchroo (Harvard University, Cambridge, MA) and were previously described. 12 Mice used for phenotypic analyses of salivary gland infiltrating cells were 14-to 15-week-old females and 19-to 21-week-old males. Donor and recipient mice for transfer studies were 6-12 weeks old. Mice used for in vivo CD25 depletion studies were 5-6 weeks old at the start of antibody treatment. Mice were maintained and used in accordance with the Institutional Animal Care and Use Committee Guidelines of the University of Iowa and the Children's Hospital of Philadelphia.
Histological characterization of salivary and lacrimal glands
Inflammation of submandibular salivary glands and exorbital lacrimal glands was quantified as previously described. 12, 13 Briefly, glands were formalin-fixed, processed and embedded in paraffin. Five-micrometre sections were stained with haematoxylin & eosin and analysed by standard light microscopy. Inflammation was quantified by a blinded observer using standard focus scoring as previously described 12, 13 with focus score reported as number of foci (aggregates of 50 or more mononuclear cells) per 4-mm 2 tissue area. Tissue areas were measured using either Nikon NIS-ELEMENTS BR 3.1 software or IMAGEJ software 14 as previously described. 12, 13 Representative light microscopic images were obtained using Nikon NIS-ELEMENTS IMAGING software (Nikon Instruments Inc., Melville, NY).
Lymphocyte isolation
Lymphocytes were isolated from cervical lymph nodes (LNs) or submandibular salivary glands by dissociating the tissues with the end of a 3-ml syringe plunger through 70-lm (for LNs) or 40-lm (for salivary glands) nylon mesh in RPMI-1640 (Life Technologies, Waltham, MA) supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100 lg/ml streptomycin, (Life Technologies) and 50 lM b-mercaptoethanol (Sigma-Aldrich, St Louis, MO) (complete RPMI). Cervical LNs in this study include mandibular, accessory mandibular and superficial parotid LNs. 15 For dissection of submandibular salivary glands, the overlying cervical LNs were first removed followed by careful dissection of submandibular salivary glands from surrounding parotid gland tissue and then removal of the intimately associated sublingual salivary glands to ensure that the glands of interest were specifically isolated from surrounding lymphoid tissues and other salivary tissue. Red blood cells were lysed using ACK lysing buffer (Lonza, Mapleton, IL). Peripheral blood samples were collected and mononuclear cells were isolated with Histopaque-1083 (Sigma-Aldrich) as previously described.
12
Flow cytometry and fluorescence-activated cell sorting Lymphocytes were analysed by flow cytometry using a BD LSR II or BD FACSCanto (BD Biosciences, San Jose, CA) for acquisition and FLOWJO software (Treestar Inc., Ashland, OR) for analysis. The lymphocyte gate was established by gating on forward-scatter area by side-scatter area followed by forward-scatter area by forward-scatter width to exclude singlets. Additional gating is specified in the figure legends. For sorting of Treg cells, cells from Foxp3 GFP reporter NOD mice were labelled with fluorophore-conjugated anti-CD4 antibody and purified by fluorescence-activated cell sorting (FACS) based on CD4 and Foxp3 GFP expression using a FACSAria II sorter (BD Biosciences). The non-Treg cells were sorted in a similar way to include all other cells within the lymphocyte singlet gate that were not CD4 + Foxp3 + (i.e. all CD4 + Foxp3 À and CD4 À lymphocytes). For all sorts, the purified CD4 + Foxp3 + Treg cell population was > 95% pure and the purified non-Treg cell populations contained < 2% CD4 + Foxp3 + cells. Antibodies were purchased from BD Biosciences, eBioscience (San Diego, CA), or BioLegend (San Diego, CA). Antibody clones included the following: CD3e (145-2c11), CD4 (GK1.5 or RM4-5), CD8a (53-6.7), Foxp3 (FJK-16s), CD19 (1D3), T-cell receptor-b (TCR-b; H57-597).
In vivo Treg cell depletion
To deplete Treg cells in vivo, mice were treated for 4 weeks with weekly intraperitoneal injections of 0Á5 mg anti-CD25 monoclonal antibody (clone PC-61.5.3) or rat IgG1 isotype control antibody (clone HRPN) (Bio X Cell, West Lebanon, NH).
Adoptive transfer model of Sj€ ogren syndrome
The adoptive transfer model was performed as previously described. 12, 13 Briefly, bulk cervical LN cells were isolated, pooled and 5 9 10 6 cells were transferred intravenously to NOD-SCID recipient mice. Five to seven weeks later salivary and lacrimal glands were analysed histologically and lymphocytes were analysed by flow cytometry. For Treg cell depletion studies, 5 9 10 6 non-Treg cells were transferred alone or with CD4 + Foxp3 + Treg cells at a physiological ratio based on the pre-sort donor nonTreg : Treg ratio. Donor and recipient mice were 6-12 weeks old. All donors and recipients tested negative for glucosuria at time of tissue harvest. Testosterone treatment of female NOD-SCID recipient mice was performed as previously described. 13 Briefly, placebo pellets or those containing testosterone (45 mg/pellet, 90-day release) (Innovative Research of America, Sarasota, FL) were implanted subcutaneously in the subscapular region of female NOD-SCID mice 1 week before adoptive transfer of donor cells.
Statistical analysis
Statistical analyses were performed with PRISM software version 7.00 (GraphPad, San Diego, CA). Mann-Whitney U-test was used for two-group comparisons of non-normally distributed data (focus scores) and unpaired Student's t-test was used for two-group comparisons of data that approximated normal distribution (flow cytometry data). Paired Student's t-test was used to compare flow cytometry data between two different sites within the same mouse. All two-group comparisons were two-tailed. Unpaired Student's t-tests were corrected for multiple comparisons where appropriate using the Holm-Sidak method. Paired Student's t-test was used for two-group comparisons of cells isolated from different locations within the same individual mice. P-values < 0Á05 were considered significant.
Results
Sex-specific development of sialadenitis in the NOD mouse model of Sj€ ogren syndrome
The NOD mouse is a well-established model of Sj€ ogren syndrome. Inflammation of the salivary glands is sex-specific with sialadenitis spontaneously developing in female but not in male NOD mice (Fig. 1a,b and refs 6,7). Similar to human Sj€ ogren syndrome, [16] [17] [18] salivary gland infiltrates in affected NOD mice, even at early stages, are dominated by CD4 T cells but also include CD8 T cells and B cells (Fig. 1c,d and refs [19] [20] [21] . Among the abundant CD4 + T cells, CD4 + Foxp3 + Treg cells were detected in the salivary glands of female NOD mice in proportions comparable to those in the salivarygland-draining cervical LNs (Fig. 1d) . Surprisingly, similar proportions of B cells and T-cell subsets were found in male salivary glands ( Fig. 1c,d ; see Supplementary material, Fig. S1 ). Although the proportions of these cells were comparable between gland and LN, the number of cells recovered from the salivary glands was routinely 50-to 150-fold lower than that recovered from the cervical LNs. Hence, in female NOD mice, salivary gland inflammation was not associated with a selective exclusion of Treg cells from the glands; however, the possibility remained that a salivary-gland-protective subset of Treg cells was either absent or was present but dysfunctional. Similarly, the lack of spontaneous sialadenitis in male NOD mice suggested that male NOD mice may have functional salivary-gland-protective Treg cells.
In vivo Treg cell depletion is sufficient to drive dacryoadenitis but not sialadenitis
To determine if salivary-gland-protective Treg cells prevent sialadenitis in male NOD mice, we used an in vivo Treg cell depletion model, taking advantage of the expression of CD25 on the majority of Treg cells. 22 Mice were injected with an anti-CD25 antibody or isotype control antibody for four consecutive weeks and salivary and lacrimal glands were analysed for inflammation 9 weeks after the initial injection. Flow cytometric analyses of cervical LN cells demonstrated a significant reduction in CD4 + Foxp3 + Treg cells in male NOD mice treated with the anti-CD25 antibody relative to those treated with the isotype control antibody, indicating that anti-CD25 antibody treatment was effective at reducing this population (Fig. 2a) . However, this Treg cell depletion in male NOD mice did not promote development of sialadenitis (Fig. 2b) . In contrast, lacrimal gland inflammation (which spontaneously develops in male NOD mice) was comparable whether Treg cells were depleted or not (Fig. 2c) . Longitudinal analyses of peripheral blood cells from these treated male mice demonstrated that the anti-CD25 antibody treatment was effective in decreasing Treg cells throughout the course of the experiment (Fig. 2d) .
To confirm that in vivo anti-CD25 antibody treatment does not antagonize sialadenitis development and was sufficient to promote autoimmunity, we performed this treatment in female NOD mice and assessed the development of sialadenitis and dacryoadenitis. Sialadenitis occurs spontaneously in female NOD mice, but dacryoadenitis does not occur spontaneously in female NOD mice because of the presence of lacrimal-gland-protective Treg cells. 13 Similar to males, flow cytometric analyses of female cervical LN cells showed a significant reduction in the percentage of CD4 + Foxp3 + Treg cells in anti-CD25 antibody-treated females (Fig. 2e) . Comparable sialadenitis was observed in female NOD mice treated with the isotype control antibody or the anti-CD25 antibody (Fig. 2f) . Notably, although little to no dacryoadenitis was observed in female NOD mice treated with the isotype control antibody, treatment with the Treg celldepleting antibody induced dacryoadenitis (Fig. 2g ).
These data confirm our earlier findings that lacrimalgland-protective Treg cells are present in female NOD mice 13 and suggest that the partial Treg cell depletion capable of driving dacryoadenitis in females does not drive sialadenitis in male NOD mice.
Male NOD mice have salivary-gland-protective Treg cells
Male NOD mice do not spontaneously develop sialadenitis ( Fig. 1) . This may be a result of (i) the lack of functional pathogenic effector cells (including specific T-cell subsets, B cells, antigen-presenting cells and other P-value determined by multiple t-tests with correction for multiple comparisons using the Holm-Sidak method. **P < 0Á01, ***P < 0Á001. (e) Representative flow cytometry plots of cells isolated from the cervical LNs of female NOD mice that received treatment with anti-CD25 antibody or isotype control antibody for four consecutive weeks starting at week 0. Plots were gated on singlet T cells (CD3e   +   ) . Graphs show data from one experiment (anti-CD25: n = 6; isotype: n = 3). Symbols represent individual mice, bars represent means. P-value determined by unpaired Student's t-test. pathogenic populations), (ii) the resistance of male salivary glands to being targeted in an autoimmune attack, or (iii) the presence of functional salivary-gland-protective Treg cells. The lack of sialadenitis in male NOD mice upon in vivo Treg cell depletion (Fig. 2b) may suggest that the latter is less likely; however, in vivo Treg cell depletion with anti-CD25 antibody induced only partial Treg cell depletion (Fig. 2a,d ). Although such partial depletion was sufficient to drive dacryoadenitis in female NOD mice, the possibility remained that male NOD mice have a Treg cell population capable of protecting salivary glands even in the face of partial depletion. To address these possibilities, we used an adoptive transfer model in which cervical LN cells were isolated from NOD donor mice and transferred intravenously to lymphocyte-deficient NOD-SCID recipient mice, as previously described. 12, 13 Similar to female-specific sialadenitis that develops spontaneously in NOD mice, transfer of bulk cervical LN cells from NOD donors to NOD-SCID recipients resulted in significantly greater sialadenitis in femaleto-female transfers compared with male-to-male transfers (Fig. 3a) . Hence, similar to the lack of spontaneous sialadenitis in male NOD mice, male NOD-SCID recipient mice were protected from sialadenitis in our transfer model.
To determine if a more complete depletion of Treg cells would promote sialadenitis in male mice we used male NOD mice expressing a Foxp3 GFP reporter to purify Treg cells and non-Treg cells from the cervical LNs of male NOD mice by FACS (Fig. 3b) . We then transferred either non-Treg cells alone or non-Treg cells with Treg cells added back at physiological ratios (non-Treg + Treg) to male NOD-SCID recipients. As with our bulk transfers (Fig. 3a) little to no sialadenitis was observed in recipients of non-Treg + Treg cells, whereas recipients of the Treg cell-depleted non-Treg donor cells developed significantly more sialadenitis, including one recipient that developed so much inflammation that individual foci coalesced and could not be accurately enumerated (designated diffuse) (Fig. 3c) . Flow cytometric analyses of T-cell populations in the cervical LNs of recipient mice showed repopulation of the Treg cells at takedown but at a significantly decreased proportion compared with recipients of non-Treg + Treg cells (Fig. 3d) . Although the overall degree of inflammation (i.e. focus scores) was slightly lower in some mice compared with that in female recipient mice ( Fig. 3c compared with Fig. 3a ), these results demonstrate that male NOD mice have (i) effector T cells that can target salivary glands, (ii) salivary glands that are not intrinsically resistant to being targeted by pathogenic T cells, and (iii) a population of Treg cells that prevent sialadenitis.
To determine if these salivary-gland-protective Treg cells were capable of preventing sialadenitis in female mice, we transferred bulk cervical LN cells (which include Treg cells) from male NOD donors to either male or female NOD-SCID recipients. Despite little to no sialadenitis in male recipients, the same pool of donor cells caused significantly more sialadenitis in female recipients (Fig. 3e) . This was not the result of a decrease in proportion of Treg cells in female recipients (Fig. 3f) . Hence, male NOD mice have salivary-gland-protective Treg cells capable of preventing sialadenitis in male, but not female, recipient mice.
Female NOD mice develop sialadenitis in the presence or absence of Treg cells
The presence of salivary-gland-protective Treg cells in male NOD mice that were incapable of preventing transfer of sialadenitis to female NOD-SCID mice (Fig. 3e) suggested that sialadenitis in females may be the result of dysfunction of salivary-gland-protective Treg cells. Accordingly, transfer of female non-Treg cells or non-Treg + Treg cells to female NOD-SCID recipients resulted in a similar degree of sialadenitis regardless of the presence or absence of Treg cells in the donor population (Fig. 4a) . Similar to male-tomale transfers (Fig. 3d) , Treg cells were partially repopulated in recipients of non-Treg cells at takedown but were still significantly lower than in recipients of nonTreg + Treg cells (Fig. 4b) . Hence, in female NOD mice, Treg cells were incapable of significantly modulating the degree of sialadenitis.
Female Treg cells prevent sialadenitis in male mice
The ability of male salivary-gland-protective Treg cells to function in males but not in females (Fig. 3e) prompted us to determine if this was also true for female salivarygland-protective Treg cells: can female Treg cells prevent sialadenitis in males but not in females? To address this question, we isolated bulk cervical LN cells from female NOD donors and transferred them into male or female NOD-SCID recipients. In contrast to the development of sialadenitis in female recipients, male recipients of the same population of female donor cells developed significantly less sialadenitis (Fig. 5a) . A similar proportion of Treg cells was observed in male and female recipients, suggesting that this was not the result of an increase in the proportion of Treg cells in the male recipients (Fig. 5b) . We considered the possibility that the sex-based difference in salivary gland disease development was due to sex hormones. Previous studies in NOD mice had shown that altering female sex hormones through castration did not modulate the development of sialadenitis in females, 6 whereas castration of males increased development of sialadenitis (Fig. 5c) . (Fig. 5d) . Rather, this was associated with morphological differences in salivary glands, with castrated male salivary glands adopting a more female-like histological appearance (see Supplementary material, Fig. S2 ). We, therefore, chose to determine if testosterone was a key protective factor in the development of sialadenitis in our transfer model. We transferred bulk cervical LN cells from female donor mice to testosteronetreated or placebo-treated female NOD-SCID recipient mice and found that testosterone-treated recipients developed significantly less sialadenitis (Fig. 5e) . No difference in the percentage of Treg cells was observed between testosterone-treated or placebo-treated recipients, again demonstrating that the protective effect was not the result of differences in the proportion of Treg cells repopulating the recipient mice (Fig. 5f ). To determine if Treg cells were required for the prevention of sialadenitis when female cervical LN cells were transferred to a testosterone-rich male environment, we transferred FACS-purified non-Treg cells or non-Treg + Treg cells from female NOD donors into male NOD-SCID recipients. As expected, recipients of non-Treg cells had a significantly decreased proportion of Treg cells within the cervical LNs at takedown (Fig. 5g) . Strikingly, sialadenitis developed in recipients of non-Treg cells but not in those receiving non-Treg + Treg cells (Fig. 5h) . The male environment protects from sialadentitis by promoting salivary-glandprotective Treg cells. Collectively, these data indicate that salivary-gland-protective Treg cells are present in the cervical LNs of both male and female NOD mice, yet they fail to prevent the development of autoimmune sialadenitis in a female host.
Discussion
Treg cells suppress immune cell activation and are required to prevent autoimmunity. 8 Although the exact nature of Treg cell-mediated prevention of autoimmunity is complex and not completely understood, multiple studies demonstrate that Treg cells function in an organ-specific manner. [24] [25] [26] This was observed in early studies in rats in which T cells isolated from rats with intact thyroid glands were capable of preventing experimental autoimmune thyroiditis and experimental autoimmune diabetes, whereas T cells isolated from rats in which the thyroid was ablated in utero failed to protect against the development of experimental autoimmune thyroiditis but could still confer protection against experimental autoimmune diabetes. 24 In a mouse model of autoimmune prostatitis, CD4 T cells could only suppress disease if they were isolated from male mice, but not if they were from female mice or prostatedeficient male mice. 25 Induced Treg cells from NOD mice could only provide protection against type 1 diabetes when their cognate antigen was present in vivo. 26 These studies suggest that the organ-specific protective function of Treg cells is based on antigen specificity. In further support of antigen-specific function of Treg cells, Treg cells with distinct TCRs were enriched within different anatomically located LN groups 27 and preferentially homed to their LN of origin following adoptive transfer. 28 Functionally, several studies provide evidence that organ-protective Treg cells are enriched within organ-draining LNs. [29] [30] [31] These studies formed the basis for our recent studies using transfers of cells from cervical LNs (which drain lacrimal and salivary glands) to demonstrate that protection from dacryoadenitis in female NOD mice was associated with functional lacrimal-gland-protective Treg cells. Here we show that male NOD mice were protected from sialadenitis because of the presence of salivary-gland-protective Treg cells. In contrast, Treg cells were incapable of preventing sialadenitis in female NOD mice or female NOD-SCID recipients, accounting for the female-specific susceptibility to salivary gland autoimmunity. Collectively, our studies suggest that the organ-specific autoimmunity observed in NOD mice is the result of factors that disrupt organ-specific Treg cell function. The fact that the organ-specific Treg cell dysfunction was not transferable between males and females (e.g. female salivary-gland-protective Treg cells were dysfunctional in females but functional in males) suggested that the factors driving disease development were either reversible or were Treg cell extrinsic. This could be due to direct effects on non-Treg immune cells (e.g. effector T cells or antigen-presenting cells) that allow them to resist Treg cell-mediated suppression or due to effects on other cell types, such as cells within the target organs themselves (e.g. acinar or ductal epithelial cells). In the NOD mouse, salivary gland autoimmunity is thought to develop in three distinct, yet continuous phases: (i) defects in salivary gland organogenesis and apoptosis of salivary gland acinar cells; (ii) lymphocytic autoimmune attack on glands; (iii) gland destruction and dysfunction. 19, [32] [33] [34] Therefore it seems plausible that the factors driving disease could affect both immune and nonimmune cell types at different stages of disease development. Notably, salivary gland epithelial cells in female NOD-SCID mice exhibited histological changes in the absence of inflammation with a decrease in the acinar to ductal cell ratio over time. 35 This may be the result of increased epithelial cell apoptosis independent of inflammation as salivary gland epithelial cells in NOD-SCID mice express a similar increase in pro-apoptotic molecules to that found in NOD mice. 36 Whether these changes are specific to females even in NOD-SCID mice has not been formally explored, but the histological differences in haematoxylin & eosin-stained sections of submandibular salivary glands from female and male NOD mice (Fig. 1b) were also apparent in NOD-SCID mice (see Supplementary material, Fig. S2 and data not shown) suggesting that the sex differences in salivary gland morphology are not a sequela of the autoimmune process but may instead be a relevant driving factor. The strikingly similar morphological differences in sections of salivary glands from castrated and sham-castrated male NOD mice (see Supplementary material, Fig. S2 ) to those in female and male NOD and NOD-SCID mice suggest that androgens are a key factor in these differences. But exactly how such morphological changes reflect a predisposition to sialadenitis is not yet known.
Sex hormones are obvious candidates for driving the sex-specific differences in autoimmunity that are observed in the NOD mouse model of Sj€ ogren syndrome. In our study, treatment of female mice with testosterone reduced the degree of salivary gland inflammation, suggesting that testosterone functions in a protective manner in the context of salivary gland inflammation. Similar effects have been observed in other mouse models of Sj€ ogren syndrome, including in the NZB/NZW F 1 mouse model in which treatment with testosterone reduced the number of lymphocytic foci in the salivary gland. 37 Similarly, castrated male NOD mice showed significantly elevated levels of sialadenitis relative to sham-castrated controls (Fig. 5c) . 6, 23 In contrast to protective effects on salivary gland autoimmunity, testosterone promotes dacryoadenitis in NOD mice. 6, 13, 38 Castration of male NOD mice protected from spontaneous dacryoadenitis, 6, 38 and testosterone treatment of female NOD-SCID recipients of female cervical LN cells promoted dacryoadenitis. 13 Collectively, these studies demonstrate that the effects of testosterone on salivary and lacrimal gland autoimmunity in NOD mice are opposite and that testosterone is a key factor that drives lacrimal gland autoimmunity while protecting from salivary gland autoimmunity. Interestingly, in NOD mice modified to express the C57BL/10 mousederived MHC locus (H2 b haplotype) in place of the NOD H2 g7 haplotype, female mice develop both salivary and lacrimal gland inflammation. 39 Hence, comparing disease mechanisms in these NOD.B10 mice and wild-type NOD mice may provide insight into both hormonal and non-hormonal factors driving salivary and lacrimal gland disease.
In contrast to testosterone, the lack of an effect on sialadenitis or dacryoadenitis in ovariectomized female NOD mice suggests that female sex hormones do not influence disease in salivary or lacrimal glands. 6 However, reports in other models suggest that oestrogen may play a protective role. For example, aromatase knockout mice, which fail to synthesize oestrogens, develop sialadenitis. 40 In a day 3 thymectomy model, ovariectomized females developed more sialadenitis than sham controls. 37 Further, the increase in ductal cell death observed in the salivary glands of ovariectomized mice suggests that oestrogen promotes the survival of these cells 37 and so may play a protective role in disease development. In contrast, oestrogen promotes interleukin-17 (IL-17) production 41 and increased proportions of IL-17-producing cells have been associated with more severe sialadenitis in the C57BL/6.NOD-AEC1AEC2 mouse model of Sj€ ogren syndrome. 42 Therefore, oestrogens appear to have different effects on salivary gland inflammation and the exact role is probably modified by other factors, including genetic and strain-specific effects, and possibly also the microbiome. 23 Our transfer studies here demonstrated the presence of functional salivary-gland-protective Treg cells in male NOD mice, and our previous studies demonstrated functional lacrimal-gland-protective Treg cells in female NOD mice. It was somewhat surprising to note that the in vivo Treg cell depletion was not sufficient to drive salivary gland autoimmunity in male NOD mice. This may be because of the incomplete depletion of Treg cells by this method; however, similar partial Treg cell depletion in female NOD mice resulted in lacrimal gland autoimmunity. This may reflect a fundamental difference in mechanisms of lacrimal versus salivary gland autoimmunity. Alternatively, this may reflect an underlying increased propensity for female NOD mice to develop autoimmune manifestations such that a partial Treg cell depletion was able to drive the females to develop autoimmunity of a normally unaffected target organ (e.g. lacrimal glands). In general, the mammalian immune response in females is stronger than that in males, as demonstrated by greater pro-inflammatory responses, T-cell proliferation and antibody responses in females upon infection or vaccination. 43 This was also observed in several mouse models of Sj€ ogren syndrome. In the NOD.H2 h4 mouse model, female mice have more severe sialadenitis and an increased number of CD45 cells, including CD4 T cells, in salivary gland infiltrates. 44 A comparison of sex differences in sialadenitis and dacryoadenitis also showed more severe disease in females of several non-NOD strains. 7 Hence the female host environment appears to favour effector cells in the balance between effector and regulatory cells. Therefore, transient, incomplete depletion of Treg cells in females may more easily allow development of autoimmunity, whereas in a male host, a higher threshold must be overcome for an autoimmune attack to occur, and partial depletion of Treg cells is simply not sufficient to overcome this barrier. Along these lines, recent studies in humans found increased frequency of an extra X chromosome in males and females with Sj€ ogren syndrome 45, 46 supporting the role of X chromosome genes in increasing risk of autoimmunity. Similarly, epigenetic DNA methylation changes may contribute to an increased dose effect by allowing access to genes on the inactivated X chromosome in females with normal karyotypes. 47 The ability of Treg cells within male or female donor cervical LN cells to prevent the co-transferred effector T cells from mediating salivary gland autoimmunity in a male host but not in a female raises the question as to which effector cell population may be modulated by Treg cells to prevent salivary gland autoimmunity. In the C57BL/6.NOD-AEC1AEC2 model of Sj€ ogren syndrome, evidence for a sexually dimorphic role for IL-17 in salivary gland autoimmunity has been observed. 42 Genetic ablation of IL-17 restored salivary gland function in both sexes, but greater effects were observed in females relative to males, including a greater reduction in the immune cell infiltrate into the gland, and so a greater reduction in overall focus score. 42 Notably, splenocytes from oestrogen-treated mice have increased IL-17 expression and secrete higher levels of IL-17 ex vivo. 41 Hence, it is possible that pathogenic IL-17-producing effector T cells may be modulated by Treg cells in a male environment, whereas this mechanism is not sufficient to protect against autoimmunity in females. Another consideration is the possibility that host cells within the recipient mice, such as epithelial cells or antigen-presenting cells, may be selectively resistant to Treg cell-mediated suppression within the female host. These possibilities remain to be explored. NOD mice display sex-specific differences in the development of salivary and lacrimal gland autoimmunity that can be, in part, attributed to sex hormones. A key outstanding question is which cells are targeted by sex hormones in the promotion or prevention of organ-specific autoimmunity. The androgen receptor and oestrogen receptors are expressed within salivary and lacrimal glands, [48] [49] [50] suggesting that hormones can impact the cells that make up the glands. Studies on salivary glands from non-autoimmune-prone mice demonstrate that significant gene expression differences exist between males and females, affecting genes involved in processes such as development, growth, transcription, metabolism, signal transduction and receptor activity, among others. 51, 52 Some of these differences can be directly attributed to the action of hormones as testosterone treatment affected thousands of genes in the salivary glands of orchidectomized male BALB/c mice. 53 Further support for the effect of sex hormones on salivary glands is observed in female or castrated males, where rapid morphological changes in the salivary glands are observed upon androgen treatment. 54, 55 Similar morphological differences are clearly apparent when comparing male and female salivary glands from NOD mice or NOD-SCID mice ( Fig. 1b; see Supplementary material, Fig. S2 ) or castrated and sham-castrated male NOD mice (see Supplementary material, Fig. S2 ). Despite these reports on the effects of sex hormones on the salivary glands themselves, the specific molecular mechanisms by which these changes promote or protect from autoimmunity is unclear. Hence, using the NOD mouse model to address these questions to delineate the mechanisms by which hormones exert their effects to drive salivary and lacrimal gland autoimmunity will further our understanding of the role of sex hormones in Sj€ ogren syndrome and other autoimmune diseases.
